{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T10:03:11Z","timestamp":1746180191244,"version":"3.38.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejim.2024.07.026","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T21:42:50Z","timestamp":1722289370000},"page":"134-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Quinolones or macrolides for adults with Legionnaires\u2019 disease and respiratory failure?"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-4277","authenticated-orcid":false,"given":"Lorna","family":"Pairman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.07.026_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2023.09.013","article-title":"Legionella pneumonia in hospitalized adults with respiratory failure: quinolones or macrolides?","volume":"120","author":"Ruiz-Spinelli","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2024.07.026_bib0002","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/jac\/dkx007","article-title":"Antimicrobial strategy for severe community-acquired legionnaires\u2019 disease: a multicentre retrospective observational study","volume":"72","author":"Cecchini","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ejim.2024.07.026_bib0003","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.medin.2012.05.010","article-title":"Community-acquired legionella pneumonia in the intensive care unit: impact on survival of combined antibiotic therapy","volume":"37","author":"Rello","year":"2013","journal-title":"Med Intens (Engl ed)"},{"issue":"3","key":"10.1016\/j.ejim.2024.07.026_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jmii.2017.08.018","article-title":"Community-acquired Legionnaires' disease at a medical center in northern Taiwan","volume":"52","author":"Kao","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.ejim.2024.07.026_bib0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jiac.2020.10.002","article-title":"Meta-analysis of fluoroquinolones versus macrolides for treatment of legionella pneumonia","volume":"27","author":"Kato","year":"2021","journal-title":"J Infect Chemother"},{"issue":"11","key":"10.1016\/j.ejim.2024.07.026_bib0006","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/cid\/ciaa441","article-title":"Are fluoroquinolones or macrolides better for treating Legionella pneumonia? A systematic review and meta-analysis","volume":"72","author":"Jasper","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ejim.2024.07.026_bib0007","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/jac\/dku159","article-title":"Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis","volume":"69","author":"Burdet","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ejim.2024.07.026_bib0008","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40121-022-00635-7","article-title":"Legionnaires\u2019 disease: update on diagnosis and treatment","volume":"11","author":"Viasus","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"5","key":"10.1016\/j.ejim.2024.07.026_bib0009","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkg191","article-title":"Legionnaires' disease: a rational approach to therapy","volume":"51","author":"Roig","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ejim.2024.07.026_bib0010","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:04:00Z","timestamp":1742036640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524003236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":10,"alternative-id":["S0953620524003236"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.026","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinolones or macrolides for adults with Legionnaires\u2019 disease and respiratory failure?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}